The inhibitory effect of lotus leaf extract on hyperuricemia and its potential mechanism

Abstract

Objective: Lotus leaf is a traditional Chinese herb that has been used successfully for centuries for relieving edema by inducing diuresis. Based on its good clinical evidence and anti-hypertensive effectiveness, this study aimed to investigate the potential mechanism of the hyperuricemic inhibitory effects of lotus leaf crude extract (LL) and lotus leaf total alkaloids fraction (LA). Methods: The xanthine oxidase (XOD) inhibitory effect of LL and LA was analyzed in vitro by determining mRNA expression and protein expression levels of hepatic XOD. The hyperuricemic inhibitory effect of the lotus leaf was analyzed in vivo in a potassium oxonate (PO)-induced rat model by determining mRNA expression for renal urate transporters. Results: At a concentration of 40 μg/mL, LL and LA suppressed XOD enzymatic activity by 37.35% ± 9.50% and 47.73% ± 8.32%, respectively. Both LL and LA administration significantly reduced the concentration of uric acid in the serum and liver of PO-induced hyperuricemic rats. Both LL and LA administration could inhibit XOD mRNA and protein expression, activate renal organic anion transporter 1/3 mRNA expression, and inhibit renal urate reabsorption by decreasing renal GLUT9 and renal urate transporter 1.Conclusions: Insight was gained into the mechanism behind the hyperuricemic inhibitory effects of LL and LA. Our results suggest that they act on two targets: decreasing the production of uric acid by inhibiting mRNA and protein expression of XOD in the liver, and regulating the mRNA expression of renal urate transporters in the kidneys.

Keywords

Hyperuricemia / Lotus leaf / Renal urate transporters / Uric acid / Xanthine oxidase

References

[[1]] Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41(6):1183-1190.

[[2]] Ruilope LM, Garcia-Puig J. Hyperuricemia and renal function. Curr Hypertens Rep 2001;3(3):197-202.

[[3]] Shi YW, Wang CP, Wang X, et al. Uricosuric and nephroprotective properties of Ramulus Mori ethanol extract in hyperuricemic mice. J Ethnopharmacol 2012;143(3):896-904.

[[4]] Ardan T, Kovaceva J, Cejkova J. Comparative histochemical and immunohistochemical study on xanthine oxidoreductase/xanthine oxidase in mammalian corneal epithelium. Acta Histochem 2004;106(1):69-75.

[[5]] Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 2006;58(1):87-114.

[[6]] Tao B, Chen MY, Li XN, et al. The information on the research of pharmaceutical used part of Heye (lotus leaf). Inform Tradit Chin Med 2001;18(2):14.

[[7]] Wu MJ, Wang L, Weng CY, et al. Antioxidant activity of methanol extract of the lotus leaf (Nelumbo nucifera Gertn.). Am J Chin Med 2003;31(5):687-698.

[[8]] Saengkhae C, Arunnopparat W, Sungkhajorn P. Antioxidant activity of Nelumbo nucifera Gaertn on oxidative stress-induced erythrocyte haemolysis in hypertensive and normotensive rats. J Physiol Sci 2007;20(2):70-78.

[[9]] Ono Y, Hattori E, Fukaya Y, et al. Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. J Ethnopharmacol 2006;106(2):238-244.

[[10]] Tao W, Deqin Z, Yuhong L, et al. Regulation effects on abnormal glucose and lipid metabolism of TZQ-F, a new kind of traditional Chinese medicine. J Ethnopharmacol 2010;128(3):575-582.

[[11]] Morikawa T, Xie H, Matsuda H, et al. Bioactive constituents from Chinese natural medicines. XVII. constituents with radical scavenging effect and new glucosyloxybenzyl 2-isobutylmalates from Gymnadenia conopsea. Chem Pharm Bull (Tokyo) 2006;54(4):506-513.

[[12]] Nguyen MT, Awale S, Tezuka Y, et al. Hypouricemic effects of acacetin and 4,5-o-dicaffeoylquinic acid methyl ester on serum uric acid levels in potassium oxonate-pretreated rats. Biol Pharm Bull 2005;28(12):2231-2234.

[[13]] Mo SF, Zhou F, Lyu YZ, et al. Hypouricemic action of selected flavonoids in mice: structure-activity relationships. Biol Pharm Bull 2007;30(8):1551-1556.

[[14]] Johnson WJ, Stavric B, Chartrand A. Uricase inhibition in the rat by s-triazines: an animal model for hyperuricemia and hyperuricosuria. Proc Soc Exp Biol Med 1969;131(1):8-12.

[[15]] Spieker LE, Ruschitzka FT, Luscher TF, et al. The management of hyperuricemia and gout in patients with heart failure. Eur J Heart Fail 2002;4(4):403-410.

[[16]] Hou CW, Lee YC, Hung HF, et al. Longan seed extract reduces hyperuricemia via modulating urate transporters and suppressing xanthine oxidase activity. Am J Chin Med 2012;40(5):979-991.

[[17]] Roncal CA, Mu W, Croker B, et al. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 2007;292(1):F116-122.

[[18]] Tojo A, Sekine T, Nakajima N, et al. Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol 1999;10(3):464-471.

[[19]] Kim S, Lee CH, Kang CM, et al. Effects of increased uric acid intake on the abundance of urate-anion exchanger and organic anion transporter proteins in the rat kidney. Electrolyte Blood Press 2007;5(2):62-67.

[[20]] Enomoto A, Endou H. Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease. Clin Exp Nephrol 2005;9(3):195-205.

[[21]] Bakhiya A, Bahn A, Burckhardt G, et al. Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux. Cell Physiol Biochem 2003;13(5):249-256.

[[22]] Hediger MA, Johnson RJ, Miyazaki H, et al. Molecular physiology of urate transport. Physiology (Bethesda) 2005;20(2):125-133.

[[23]] Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002;417(6887):447-452.

[[24]] Li S, Sanna S, Maschio A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007;3(11):e194.

[[25]] Van Aubel RA, Smeets PH, van den Heuvel JJ, et al. Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. Am J Physiol Renal Physiol 2005;288(2):F327-333.

[[26]] Weinman EJ, Mohanlal V, Stoycheff N, et al. Longitudinal study of urinary excretion of phosphate, calcium, and uric acid in mutant NHERF-1 null mice. Am J Physiol Renal Physiol 2006;290(4):F838-843.

RIGHTS & PERMISSIONS

2021 Acupuncture and Herbal Medicine